aTyr Pharma ATYR EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from aTyr Pharma’s reported figures.
Based on trailing twelve months.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's EBITDA margin?
- aTyr Pharma (ATYR) reported EBITDA margin of -40,506.8% in Q4 2025.
- How has aTyr Pharma's EBITDA margin changed year-over-year?
- aTyr Pharma's EBITDA margin decreased by 41.6% year-over-year, from -28,598.3% to -40,506.8%.
- What is the long-term trend for aTyr Pharma's EBITDA margin?
- Over 3 years (2020 to 2025), aTyr Pharma's EBITDA margin has grown at a 551.1% compound annual growth rate (CAGR), from -146.7% to -40,506.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.